Lannett to purchase Silarx Pharmaceuticals
Lannett Co. plans to acquire Silarx Pharmaceuticals Inc., a manufacturer and marketer of liquid generic drug products. Financial terms of the agreement, which includes a related real estate entity, weren’t disclosed.